Other Information.
−Removed: During the fiscal quarter ended March 31, 2025, none of the Company’s directors or officers (as defined in
−Removed: Rule 16a-1(f) of the Exchange Act) adopted or terminated any contract, instruction or written plan for the purchase or sale of Company
−Removed: securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement
+Added: the three month period ended June 30, 2025, none of our executive officers or directors (as defined in Section 16 of the Securities Exchange
+Added: Act of 1934, as amended), adopted , terminated , or modified a “Rule 10-b5-1 trading arrangement” or a “non-Rule 10b5-1
+Added: trading arrangement” (as defined in Item 408(c) of Regulation S-K).
+Added: Share repurchases made
+Added: during each month to be provided by CDT.
following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
+Added: Certificate of Amendment filed with the Delaware Secretary of State on May 15, 2025 (incorporated by reference to the Company’s Current Report on Form 8-K filed on May 16, 2025).
+Added: Certificate of Amendment filed with the Delaware Secretary of State on August 5, 2025 (incorporated by reference to the Company’s Current Report on Form 8-K filed on August 8, 2025).
+Added: Second Amended and Restated Bylaws of the Company (incorporated by reference to the Company’s Current Report on Form 8-K filed on August 8, 2025).
+Added: Consulting Agreement, dated June 27, 2025, by and between the Company and Harold Eytan (incorporated by reference to the Company’s Registration Statement on Form S-3 filed on July 31, 2025).
+Added: Joint Development Agreement, dated June 3, 2025, by and between the Company and Manoira Corporation (incorporated by reference to the Company’s Current Report on Form 8-K filed on June 9, 2025).
+Added: CDT Equity Inc.
+Added: Amended and Restated 2023 Stock Incentive Plan (incorporated by reference to the Company’s Current Report on Form 8-K filed on August 8, 2025).
Certification of Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
21 unchanged sentences
thereunto duly authorized.
−Removed: PHARMACEUTICALS INC
+Added: CDT EQUITY INC
Executive Officer
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.